E-Cadherin and β-Catenin mRNA Levels Throughout Colon Cancer Progression

Journal of Surgical Research

Volumn 150, Issue 2, 2008, Pages 212-218

  Truant, Stéphanie C ^a,b   Gouyer, Valérie P ^a,b   Leteurtre, Emmanuelle A ^a   Zerimech, Farid ^a   Huet, Guillemette M ^a,b   Pruvot, François René R ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

catenin; colon cancer; E cadherin; liver metastases

Indexed keywords

BETA CATENIN; MESSENGER RNA; RNA 18S; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; COLON CARCINOMA; COLON MUCOSA; COLON RESECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; CARCINOMA; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 56449127312     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.12.800     Document Type: Article

References (34)

1. Ohlsson B., Stenram U., and Tranberg K.G. Resection of colorectal liver metastases: 25-year experience. World J Surg 22 (1998) 268 Discussion 276
2. UICC TNM Classification of Malignant Tumours (1997), Wiley-Liss, New York
3. Debruyne P., Vermeulen S., and Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 62 (1999) 393
4. Takeichi M. Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5 (1993) 806
5. Jou T.S., Stewart D.B., Stappert J., et al. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 92 (1995) 5067
6. Mareel M., and Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83 (2003) 337
7. Gagliardi G., Kandemir O., Liu D., et al. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch 426 (1995) 149
8. Bellovin D.I., Bates R.C., Muzikansky A., et al. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 65 (2005) 10938
9. Dorudi S., Hanby A.M., Poulsom R., et al. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71 (1995) 614
10. Dorudi S., Sheffield J.P., Poulsom R., et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142 (1993) 981
11. Gofuku J., Shiozaki H., Tsujinaka T., et al. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol 111 (1999) 29
12. Hugh T.J., Dillon S.A., Taylor B.A., et al. Cadherin-catenin expression in primary colorectal cancer: A survival analysis. Br J Cancer 80 (1999) 1046
13. Morin P.J., Sparks A.B., Korinek V., et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787
14. Sparks A.B., Morin P.J., Vogelstein B., et al. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58 (1998) 1130
15. Brabletz T., Jung A., Dag S., et al. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155 (1999) 1033
16. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509
17. Tetsu O., and McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422
18. Chung G.G., Provost E., Kielhorn E.P., et al. Tissue microarray analysis of β-catenin in colorectal cancer shows nuclear phospho-β-catenin is associated with a better prognosis. Clin Cancer Res 7 (2001) 4013
19. Resnick M.B., Routhier J., Konkin T., et al. Epidermal growth factor receptor, c-MET, β-catenin, and p53 expression as prognostic indicators in Stage II colon cancer: A tissue microarray study. Clin Cancer Res 10 (2004) 3069
20. Wong S.C., Lo E.S., Chan A.K., et al. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Mol Pathol 56 (2003) 347
21. World-Health-Organization International Classification of Diseases for Oncology (1991), WHO Publications
22. Debailleul V., Laine A., Huet G., et al. Human mucin genes MUC2. MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs. J Biol Chem 273 (1998) 881
23. Efstathiou J.A., Liu D., Wheeler J.M., et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA 96 (1999) 2316
24. Karatzas G., Karayiannakis A.J., Syrigos K.N., et al. E-cadherin expression correlates with tumor differentiation in colorectal cancer. Hepatogastroenterology 46 (1999) 232
25. Mayer B., Johnson J.P., Leitl F., et al. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53 (1993) 1690
26. De Leeuw W.J., Berx G., Vos C.B., et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183 (1997) 404
27. Pignatelli M., Liu D., Nasim M.M., et al. Morphoregulatory activities of E-cadherin and β-1 integrins in colorectal tumor cells. Br J Cancer 66 (1992) 629
28. Van Aken J., Cuvelier C.A., De Wever N., et al. Immunohistochemical analysis of E-cadherin expression in human colorectal tumors. Pathol Res Pract 189 (1993) 975
29. Kanazawa T., Watanabe T., Kazama S., et al. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer 102 (2002) 225
30. Cheah P.Y., Choo P.H., Yao J., et al. A survival-stratification model of human colorectal carcinomas with β-catenin and p27kip1. Cancer 95 (2002) 2479
31. van der Wurff A.A., Vermeulen S.J., van der Linden E.P., et al. Patterns of α- and β-catenin and E-cadherin expression in colorectal adenomas and carcinomas. J Pathol 182 (1997) 325
32. Bukholm I.K., Nesland J.M., and Borresen-Dale A.L. Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. (see comments). J Pathol 190 (2000) 15
33. Arnold S.M., Young A.B., Munn R.K., et al. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 5 (1999) 4028
34. D'Amico T.A., Aloia T.A., Moore M.B., et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 72 (2001) 1144